See also this year's filing and all EDGAR filings for this company.
PDF Report 0001517681_2017_Propanc_Biopharma_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001517681')"} |
Graph
Absolute values for 0001517681, Propanc Biopharma Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 362,767 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 12,527 |
| 3 | remainder_Assets | 3,848 |
| 4 | LiabilitiesCurrent | 2,944,435 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 5,426,056 |
| 9 | ResearchAndDevelopmentExpense | 1,446,948 |
| 10 | remainder_Expenses | -47,988 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -2,585,336 |
| 13 | remainder_ComprehensiveNetIncome | 30,296 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 379,142 |
| 1 | Liabilities | 2,944,435 |
| 2 | Expenses | 6,825,016 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | -2,565,293 |
| 5 | NetIncome | -9,410,352 |
| 6 | ComprehensiveNetIncome | -9,395,204 |
| 7 | BaseVar | 6,382,112 |
| 8 | EconomicCapitalRatio | -8.31 |
Edgar->Model Mapping
Feature Distribution
